Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc. > 15 years later
View:
Post by RazeKreations on Jun 08, 2023 5:41pm

15 years later

In 2008 Microbix got the rights to Kinlytic and spent the next 15 years putting everything together to bring it back on the market. Not being able to do it all alone they sought out a partner to help to realize that objective. That partnership came together almost a month ago.  The surprising part of the story is the total lack of interest it has generated from investors. Yes it is going to take another 2-3 years to bring it onto the market but after all the effort that has gone onto getting this far you would think that would have brought at least some excitement about the future.  So dissapointing with the lack of interest.
Comment by Method on Jun 08, 2023 8:23pm
Any small caps not in an ETF or paid promotes / meme stocks have no incremental buyers. Return expectations are really high and there are more opportunities than there are investors. I'm not sure what changes it.  I have asked Cameron to do a reverse stock split because at least then investors who can't buy penny stocks can participate and the shares might become marginable. Thst ...more  
Comment by rjc7 on Jun 08, 2023 11:53pm
I agree with Cameron.  Every time I've seen a reverse split the stock price dribbles down over a relatively short time to its near pre-split levels. Shareholders are left with a marginally higher stock price and now only half the shares they once held.  What we really need are a couple of Q's with an earnings surprise.  
Comment by wizzdumb on Jun 09, 2023 10:41am
Big QAPs deals are coming and so is the next two million Kinlytic payment. The team confirmed they are the real thing by closing a fantastic deal and they have no control over the reaction of the market. They will keep compressing the spring and at some point it will be impossible to ignore. Should be over a dollar at this point so you can still get it for half off. Keep up the great work Cameron! ...more  
Comment by Method on Jun 09, 2023 1:30pm
I'm suggesting a 10-1 reverse split so we get the benefits of not being a penny stock and being marginable. I think the scenarios you are referring to are usually about a company trying to raise more capital. We really shouldn't need to at this point and especially at these prices.
Comment by tasman99 on Jun 11, 2023 11:23am
AGREE lack of interest is very disappointing
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities